SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-369587
Filing Date
2017-12-14
Accepted
2017-12-14 16:54:03
Documents
4
Period of Report
2017-12-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d488780d8k.htm 8-K 275928
2 EX-99.1 d488780dex991.htm EX-99.1 9661
3 GRAPHIC g488780g1214141808465.jpg GRAPHIC 6106
4 GRAPHIC g488780g20w59.jpg GRAPHIC 125747
  Complete submission text file 0001193125-17-369587.txt   468499
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36281 | Film No.: 171256717
SIC: 2834 Pharmaceutical Preparations